Mark Cuban Made More From Hedging Yahoo Stock Than the Sale
In 1999, Mark Cuban reportedly earned more from hedging Yahoo shares with a protective collar than from selling Broad...
Which Indices Do Traders Monitor Most
Learn which indices traders watch most closely and why. This quick primer covers the benchmarks that shape trading strategies and risk assessment.
26,463 articles
Alphabet Raising Billion From Stock Sale: Key Question
Alphabet is planning to raise a substantial sum from stock sales, including private placements, convertible securitie...
The $2.5 Million 401(K) Still Faces Big Tax Hits
A 73-year-old retiree with a $2.5 million 401(K) just began required minimum distributions, triggering a tax bill tha...
Upscale Wants Next: Exclusive AI-Network Push Draws $190M
Upscale AI closed a $190 million Series A-1, boosting total funding to $500 million and signaling a bold bid to becom...
Sofi's Latest Innovation Could Transform Its Growth Trajectory
SoFi is betting big on product innovation to lift growth. This deep dive explains what the latest move could mean for...
Hyperscaler Stocks Versus Infrastructure Stocks: Best Buys
As AI reshapes tech investing, two groups rise: hyperscaler stocks and AI infrastructure stocks. Learn how they inter...
Bank Account Interest Rates vs Cash Savings: A Practical Guide
If you keep cash in a basic checking or under the mattress, you may be missing out on meaningful growth. This guide s...
This Crypto Winter Much Healthier, Bitwise CIO Says
Bitwise CIO Matt Hougan contends this crypto winter much healthier than prior cycles, pointing to stronger on-chain a...
Pentagon Chief Blocks Officers From Elite Universities
The Pentagon unveils a sweeping overhaul of officer education, banning eight elite institutions and authorizing nine ...
Worst Housing Market Years: Single Women Ownership Soars
Even with rising mortgage costs and tight supply, single women are buying homes at record levels, redefining ownershi...
Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status